Browse
Search
BOH agenda 113016
OrangeCountyNC
>
Advisory Boards and Commissions - Active
>
Board of Health
>
Agendas
>
2016
>
BOH agenda 113016
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
4/24/2018 12:16:06 PM
Creation date
4/24/2018 12:13:50 PM
Metadata
Fields
Template:
BOCC
Date
11/30/2016
Meeting Type
Regular Meeting
Document Type
Agenda
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
121
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Case Studies 7 <br />TENNESSEE <br /> <br />POLITICS <br />SB1677 was filed for introduction in the state Senate on January 14th, 2016, and the <br />corresponding bill HB1823 was filed in the state House three days later. In both chambers the <br />bill was referred to the Health and Welfare Committee. The bill was first up for debate in the <br />Senate Health and Welfare Committee on March 2nd, 2016. The chief sponsor was Senator <br />Steve Dickerson, a Republican physician. <br /> <br />Dickerson briefly introduced the bill, and then turned the floor over to Dr. Leonard Brabson, the <br />Tennessee legislative chair of the American College of Obstetricians and Gynecologists. Dr. <br />Brabson strongly argued on behalf of the bill, stating that “we believe that the risks of this are <br />greatly outweighed by the benefits.” He began by making an economic argument, noting the high <br />rate of unintended pregnancies, and the cost to Medicaid of those pregnancies. He said that while <br />the ACOG formally endorses making birth control fully over the counter, making it available via <br />a collaborative practice agreement is a compromise that ACOG found acceptable. He said that <br />“self-screening by women has shown to be very appropriate” in identifying good candidates for <br />oral contraceptives, and that while “we would like for people to have annual screenings, or every <br />other year screenings… the data show that people can take birth control pills without actually <br />having to do that.” Further, countering the perception that oral contraceptives are overly risky, he <br />said that “we have riskier medications available over the counter… even Tylenol can kill you.” <br /> <br />Senator Joey Hensley asked Dr. Brabson whether he had proof that this policy would actually <br />reduce unintended pregnancies. Dr. Brabson replied that ACOG prides themselves on basing <br />policy recommendations on the available evidence. While Oregon and California’s changes were <br />too recent to measure effects, he stated that international evidence finds reductions in unintended <br />pregnancies. Sen. Hensley responded by saying he thinks the law should wait until data from <br />Oregon and California are available. Further, he thought that the law was likely not necessary <br />because birth control pills are so readily accessible, and thought that they were too high risk to be <br />available through a pharmacist. Notably, he also worried that oral contraceptives were too <br />complex for women to understand without education from a physician, stating that “some people <br />may just think that they take them one time and that helps,” rather than taking the pill each day. <br /> <br />Despite Senator Hensley’s noted concerns, the bill made it out of committee and was passed on <br />the floor of the Senate and House 28-1 and 68-22, respectively. <br /> <br /> <br />HOW IT WORKS <br />This bill authorizes pharmacists to provide hormonal contraceptives to patients over the counter <br />so long as they adhere to a “valid collaborative pharmacy practice agreement.” The bill <br />empowered the Board of Pharmacy to, along with the Board of Medical Examiners, draft <br />standard procedures for pharmacists to follow. These guidelines primarily consist of a self- <br />screening tool and education for pharmacists and patients. Then, pharmacists must partner with a <br />physician using the collaborative practice agreement. Pharmacists could then treat all women in <br />the community, not just existing patients of the supervising physician.
The URL can be used to link to this page
Your browser does not support the video tag.